These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 11176459)
1. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. Stewart RJ; Panigrahy D; Flynn E; Folkman J J Urol; 2001 Feb; 165(2):688-93. PubMed ID: 11176459 [TBL] [Abstract][Full Text] [Related]
2. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers. Joseph IB; Isaacs JT Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270 [TBL] [Abstract][Full Text] [Related]
3. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Joseph IB; Nelson JB; Denmeade SR; Isaacs JT Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654 [TBL] [Abstract][Full Text] [Related]
4. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Balbay MD; Pettaway CA; Kuniyasu H; Inoue K; Ramirez E; Li E; Fidler IJ; Dinney CP Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213 [TBL] [Abstract][Full Text] [Related]
5. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate. Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307 [TBL] [Abstract][Full Text] [Related]
6. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization. Sugamoto T; Tanji N; Sato K; Fujita H; Nishio S; Sakanaka M; Yokoyama M Anticancer Res; 2001; 21(1A):77-88. PubMed ID: 11299793 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor. Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694 [TBL] [Abstract][Full Text] [Related]
8. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model. Cheng L; Zhang S; Sweeney CJ; Kao C; Gardner TA; Eble JN Anticancer Res; 2004; 24(4):2135-40. PubMed ID: 15330153 [TBL] [Abstract][Full Text] [Related]
9. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938 [TBL] [Abstract][Full Text] [Related]
11. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models. Tesan T; Gustavsson H; Welén K; Damber JE BJU Int; 2008 Sep; 102(8):1034-9. PubMed ID: 18489523 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL J Urol; 1997 Jun; 157(6):2329-33. PubMed ID: 9146665 [TBL] [Abstract][Full Text] [Related]
16. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Huang YQ; Li JJ; Hu L; Lee M; Karpatkin S Thromb Haemost; 2001 Oct; 86(4):1094-8. PubMed ID: 11686329 [TBL] [Abstract][Full Text] [Related]
17. Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Hlatky L; Tsionou C; Hahnfeldt P; Coleman CN Cancer Res; 1994 Dec; 54(23):6083-6. PubMed ID: 7525053 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI; Soroceanu L; Strongin AY Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713 [TBL] [Abstract][Full Text] [Related]
19. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543 [TBL] [Abstract][Full Text] [Related]
20. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Pal S; Datta K; Mukhopadhyay D Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]